| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
SeqLL Inc. Warrant (NASDAQ: SQLLW)
SQLLW Technical Analysis
5
| As on 9th Jun 2023 SQLLW STOCK Price closed @ 0.11 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.56 & Strong Sell for SHORT-TERM with Stoploss of 1.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SQLLWSTOCK Price
| Open | 0.09 | Change | Price | % |
| High | 0.11 | 1 Day | 0.04 | 57.14 |
| Low | 0.05 | 1 Week | 0.06 | 120.00 |
| Close | 0.11 | 1 Month | 0.06 | 120.00 |
| Volume | 6080 | 1 Year | -0.89 | -89.00 |
| 52 Week High 1.60 | 52 Week Low 0.01 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| SQLLW Daily Charts |
SQLLW Intraday Charts |
Whats New @ Bazaartrend |
SQLLW Free Analysis |
|
|
SQLLW Important Levels Intraday
| RESISTANCE | 0.23 |
| RESISTANCE | 0.19 |
| RESISTANCE | 0.17 |
| RESISTANCE | 0.14 |
| SUPPORT | 0.08 |
| SUPPORT | 0.05 |
| SUPPORT | 0.03 |
| SUPPORT | -0.01 |
SQLLW Forecast April 2024
| 4th UP Forecast | 0.84 |
| 3rd UP Forecast | 0.61 |
| 2nd UP Forecast | 0.46 |
| 1st UP Forecast | 0.32 |
| 1st DOWN Forecast | -0.1 |
| 2nd DOWN Forecast | -0.24 |
| 3rd DOWN Forecast | -0.39 |
| 4th DOWN Forecast | -0.62 |
SQLLW Weekly Forecast
| 4th UP Forecast | 1.15 |
| 3rd UP Forecast | 0.82 |
| 2nd UP Forecast | 0.61 |
| 1st UP Forecast | 0.40 |
| 1st DOWN Forecast | -0.18 |
| 2nd DOWN Forecast | -0.39 |
| 3rd DOWN Forecast | -0.60 |
| 4th DOWN Forecast | -0.93 |
SQLLW Forecast2024
| 4th UP Forecast | 3.94 |
| 3rd UP Forecast | 2.71 |
| 2nd UP Forecast | 1.95 |
| 1st UP Forecast | 1.19 |
| 1st DOWN Forecast | -0.97 |
| 2nd DOWN Forecast | -1.73 |
| 3rd DOWN Forecast | -2.49 |
| 4th DOWN Forecast | -3.72 |
SeqLL Inc. Warrant ( NASDAQ USA Symbol : SQLLW )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SQLLW Business Profile
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It designs, develops, and manufactures genetic analysis technologies; and offers true single molecule sequencing (tSMS) platform that assists researchers to develop research, diagnostics, and therapeutics applications. The company also provides RNA sequencing services and instruments, which include Direct RNA Sequencing, a genetic testing and mapping service that captures polyadenylated RNA directly without conversion to cDNA; tSMS formalin fixed paraffin embedded (FFPE) service to analyze damaged or fragmented nucleic acids from formalin fixed paraffin embedded samples and other sources; micro RNA sequencing; and custom sequencing, and mapping and testing services, as well as gene expression studies, FFPE RNA Sequencing, biomarker discovery, fusion detection, rare mutation detection, transcriptome profiling, and cap analysis gene expression services. In addition, it offers DNA sequencing services and instruments, such as shotgun DNA sequencing, direct capture sequencing, cell free DNA sequencing, FFPE DNA sequencing, ancient DNA sequencing, and targeted sequencing, as well as microbiome studies, biomarker discovery, and tumor profiling services. Further, the company provides bioinformatics services comprising data processing, biomarkers research, pathway analysis, and gene expression analysis services, as well as undertakes various custom projects. It has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. The company serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. SeqLL Inc. was founded in 2013 and is based in Woburn, Massachusetts. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service